INCIDENCE, CAUSES AND MECHANISM OF HYPERCALCEMIA IN A HOSPITAL POPULATION IN HONG-KONG

被引:30
作者
SHEK, CC
NATKUNAM, A
TSANG, V
COCKRAM, CS
SWAMINATHAN, R
机构
[1] CHINESE UNIV HONG KONG,PRINCE WALES HOSP,DEPT CLIN ONCOL,SHA TIN,HONG KONG
[2] CHINESE UNIV HONG KONG,PRINCE WALES HOSP,DEPT MED,SHA TIN,HONG KONG
来源
QUARTERLY JOURNAL OF MEDICINE | 1990年 / 77卷 / 284期
关键词
D O I
10.1093/qjmed/77.3.1277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the incidence and causes of hypercalcaemia in a hospital population in Hong Kong, all 29 107 samples received in the laboratory in one year were analysed for plasma calcium and albumin, and samples with a plasma calcium concentration adjusted for albumin greater than 2.55 mmol/l were investigated. Plasma calcium > 2.55 mmol/l was found in 462 patients. Repeat samples were received from 302 of these and hypercalcaemia was confirmed in 183. The main causes of hypercalcaemia were malignancy (72.1 per cent), tuberculosis (6.0 per cent), and primary hyperparathyroidism (5.5 per cent). In the malignant hypercalcaemia group, carcinoma of lung was the most common (31.8 per cent) and carcinoma of breast was uncommon (3.0 per cent). Secondary deposits in bone were detected in 35 of the 122 solid tumours. In order to identify the mechanism of hypercalcaemia the contributions of renal tubular reabsorption and increased bone resorption to the plasma calcium concentration were calculated. Increased tubular reabsorption was the main contributor to hypercalcaemia in primary hyperparathyroidism and carcinoma of liver (none of whom had bony metastases) and it contributed significantly to hypercalcaemia in carcinoma of lung without bony metastases and carcinoma of oesophagus. We conclude that in Hong Kong (a) primary hyperparathyroidism is uncommon, (b) tuberculosis is an important cause and (c) humoral factors may be responsible for a relatively high proportion of cases of malignant hypercalcaemia.
引用
收藏
页码:1277 / 1285
页数:9
相关论文
共 45 条
[1]  
Heath H., Hodgson S.F., Kennedy M.A., Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community, N Engl J Med, 302, pp. 189-193, (1980)
[2]  
Christensson T., Hellstrom K., Wengle B., Clinical and laboratory findings in subjects with hypercalcaemia, Acta Med Scand, 200, pp. 355-360, (1976)
[3]  
Mays E.T., Weakley S.D., Serum multichannel autoanalysers in the detection of hypercalcaemia and hyperparathyroidism, Surg Gynecol Obstet, 131, pp. 603-608, (1971)
[4]  
Keating F.R.J., Jones J.D., Elevback L.R., Distribution of serum calcium and phosphorus values in unselected ambulatory patients, J Lab Clin Med, 74, pp. 507-514, (1969)
[5]  
Fisken R.A., Heath D.A., Bold A.M., Hypercalcaemia—A hospital survey, Q J Med, 49, pp. 405-418, (1980)
[6]  
Harrop J.S., Bailey J.E., Woodhead J.S., Incidence of hypercalcaemia and primary hyperparathyroidism in relation to the biochemical profile, J Clin Pathol, 35, pp. 345-400, (1982)
[7]  
Christensson T., Hellstrom K., Wengle B., Alveryd A., Wikland B., Prevalence of hypercalcaemia in a health screening in Stockholm, Acta Med Scand, 200, pp. 131-137, (1976)
[8]  
Heedman P.A., Stenstrom G., Clinical findings in patients with hypercalcaemia, Acta Med Scand, 193, pp. 167-173, (1973)
[9]  
McLellan G., Baird C.W., Melick R., Hypercalcaemia in an Australian hospital adult population, Med Aust, 2, pp. 354-356, (1968)
[10]  
Williamson E., Van Peener H.J., Patient benefit in discovering occult hyperparathyroidism, Arch Intern Med, 133, pp. 430-431, (1974)